Lineage Cell Therapeutics
LCTX
#8648
Rank
C$0.16 B
Marketcap
$0.70
Share price
-16.02%
Change (1 day)
-47.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of June 2024 : C$53.65 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has C$53.65 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$47.07 M-40.06%
2022-12-31C$78.53 M5.59%
2021-12-31C$74.37 M40.34%
2020-12-31C$52.99 M32.1%
2019-12-31C$40.11 M-4.2%
2018-12-31C$41.87 M-12.75%
2017-12-31C$47.99 M57.23%
2016-12-31C$30.52 M-48.8%
2015-12-31C$59.62 M74.23%
2014-12-31C$34.22 M485.01%
2013-12-31C$5.84 M35.24%
2012-12-31C$4.32 M-80.86%
2011-12-31C$22.59 M-32.17%
2010-12-31C$33.31 M159.73%
2009-12-31C$12.82 M85803.01%
2008-12-31C$0.01 M57.52%
2007-12-31C$0 M-98.55%
2006-12-31C$0.65 M-69.41%
2005-12-31C$2.13 M29.67%
2004-12-31C$1.64 M76.97%
2003-12-31C$0.93 M-54.14%
2002-12-31C$2.02 M-22.95%
2001-12-31C$2.63 M33.3%
2000-12-31C$1.97 M-74.13%
1999-12-31C$7.63 M106.88%
1998-12-31C$3.69 M
1998-06-30C$6.03 M-43.98%
1997-06-30C$10.77 M229.17%
1996-06-30C$3.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.39 B 643.99%๐Ÿ‡บ๐Ÿ‡ธ USA